And they work behind the scenes to support your bodys natural ability to recover and repair
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds. AP News
Choosing a treatment Both medications can help people lose weight so how can you decide which one is right for you
What Mechanistic Evidence Can and Cannot Prove Rodent mechanistic findings support why the warning exists Human mechanistic data does not confirm a comparable risk pathway Therefore, the burden shifts to high-quality human data Bottom Line: If GLP-1 drugs caused MTC in humans like in rodents, we'd expect clearer biologic signals in human C-cells and biomarkers
Oral versions tend to be slightly less potent, but their convenience could significantly expand GLP-1 use among people who prefer pills over injections
Starting July 1, 2026, eligible Medicare Part D beneficiaries may be able to access certain GLP-1 medications for weight management through the Medicare GLP-1 Bridge demonstration program